Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.21.2
Equity Incentive Plan (Tables)
6 Months Ended
Jun. 30, 2021
Equity Incentive Plan  
Schedule of stock option activity

The following is a summary of stock option activity for the six months ended June 30, 2021 and 2020:

Weighted-Average

Number of

Weighted- Average

Contractual Life

    

Options

    

Exercise Price

    

(In Years)

Outstanding at December 31, 2020

 

246,893

$

20.90

 

7.20

Granted

 

150,365

 

6.19

 

Expired

 

(7,599)

 

10.82

Forfeited

(12,298)

6.51

Outstanding at June 30, 2021

 

377,361

$

15.71

 

7.82

Exercisable at June 30, 2021

 

198,822

$

24.25

 

6.46

Vested and Expected to Vest at June 30, 2021

 

377,361

$

15.71

 

7.82

 

 

 

  

Outstanding at December 31, 2019

 

174,175

$

27.42

 

6.22

Granted

 

93,165

 

6.31

 

Expired

(17,114)

10.59

Forfeited

 

(3,333)

 

7.20

 

Outstanding at June 30, 2020

 

246,893

$

20.90

 

7.71

Exercisable at June 30, 2020

 

134,574

$

32.90

 

6.25

Vested and Expected to Vest at June 30, 2020

 

246,893

$

20.90

 

7.71

Schedule of weighted average assumptions

For the six months ended June 30, 2021 and 2020, the fair value of each option grant has been estimated on the date of grant using the Black-Scholes Option Pricing Model with the following weighted-average assumptions:

    

2021

    

2020

 

Risk-Free Interest Rate

 

1.82

%  

1.82

%

Expected Life

 

5.00

years

5.00

years

Expected Volatility

 

141

%  

153

%

Expected Dividend Yield

 

0

%  

0

%

Schedule of restricted stock activity

The following is a summary of restricted stock activity for the six months ended June 30, 2021 and 2020:

Weighted- Average

Number of

Weighted- Average

Remaining

    

Shares

    

Grant Date Fair Value

    

Recognition Period

Non-vested Outstanding at December 31, 2020

 

67,420

$

7.10

 

1.66

Vested

 

(37,041)

 

7.39

 

Forfeited

(2,051)

6.86

Non-vested Outstanding at June 30, 2021

 

28,328

$

6.73

 

1.59

Non-vested Outstanding at December 31, 2019

 

50,187

$

8.64

 

1.49

Awarded

49,000

6.55

Vested

 

(16,022)

 

8.82

 

Non-vested Outstanding at June 30, 2020

 

83,165

$

7.37

 

1.94

Schedule of stock-based compensation expense

The total stock-based compensation expense for employees and non-employees is included in the accompanying Condensed Consolidated Statements of Operations and as follows:

Three Months Ended June 30, 

    

Six Months Ended June 30, 

    

2021

    

2020

    

2021

    

2020

Research and Development

$

69,219

$

53,669

$

140,805

$

99,322

General and Administrative

 

193,673

 

143,382

 

339,032

 

243,649

Total Stock-Based Compensation Expense

$

262,892

$

197,051

$

479,837

$

342,971